Drugs / Polyehylene glycol-asparaginase
last change Jan 2015 re-read 3 minutes ago

Polyehylene glycol-asparaginase

Developed for
extranodal nasal NK/T cell lymphoma
Investigated by
Air Force Military Medical University, China

Trials 1

201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 2 NCT01933282 Jan 2013 → Jan 2015 extranodal nasal NK/T cell lymphoma Air Force Military Medical University, China Unknown No outcome recorded

Evidence & citations 2 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as Polyehylene glycol-asparaginase “Polyehylene glycol-asparaginase muscular injection 2500IU/ m2, d5” NCT01933282 ↗
Route Intramuscular “Polyehylene glycol-asparaginase muscular injection 2500IU/ m2, d5” NCT01933282 ↗